Core Mitochondrial Genes are Down-Regulated During SARS-CoV-2 Infection of Rodent and Human Hosts
Covid Lists
Long COVID in a Highly Vaccinated Population Infected During a SARS-CoV-2 Omicron Wave
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction
As infections rise again, why are we still ignoring long COVID?
Postacute Sequelae of SARS-CoV-2 in Children
Covixyl Nasal Spray
Israeli-Canadian firm sprays COVID, the flu away
The Science Behind BioSURE PRO Protective Nasal Spray and Why it Really Does Work – BeBioSure
FabiSpray helps clear Covid in nose faster & prevent severe disease, says Lancet study
Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2
Epidemiological Analysis of Nitric Oxide Nasal Spray (VirX™) Use in Students Exposed to COVID-19 Infected Individuals
Nothing to sneeze at: nasal sprays to tackle Covid-19
SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial
Can a nasal spray help protect you from COVID? New over the counter drug claims it does
Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection
The effects of ethyl lauroyl arginine hydrochloride( ELAH) in nasal spray on SARS-C0V-2
Intranasal Xylitol for the Treatment of COVID-19 in the Outpatient Setting: A Pilot Study
Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.
Daily Germ & Infection Defense Protection | BioShell
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Study: Topical antibiotic triggers unexpected antiviral response
Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?
Kashyap Patel, MD, Sees Link Between COVID-19 and Cancer Progression, Calls for More Biomarker Testing
Possible Cancer-Causing Capacity of COVID-19: Is SARS-CoV-2 an Oncogenic Agent?
Causal Effects of COVID‐19 on Cancer Risk
Immunologist Akiko Iwasaki: ‘We are not done with Covid, not even close’
The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
Do Bad Viruses Always Become Good Guys in the End?
PolitiFact - A claim that viruses and other pathogens always evolve to become less lethal is false
Is It Time for a Reality Check on Rapid COVID Tests?